Inicio / Metabolismo Óseo y Mineral (página 2)

Metabolismo Óseo y Mineral

Effect of Alendronate on Pseudomembrane Cytokine Expression in Patients with Aseptic Osteolysis

Última actualización 16/12/09Holt G, Reilly J, Meek RM; Journal of Arthroplasty (Dec 2009) AIM: To determine whether alendronate alters the pseudomembrane inflammatory cytokine profile in patients with established aseptic osteolysis. METHODS: A prospective, double-blind, randomized, controlled trial was conducted. Ten individuals listed for revision surgery for aseptic failure of a …

Leer más »

Bazedoxifene, a selective estrogen receptor modulator: effects on the endometrium, ovaries, and breast from a randomized controlled trial in osteoporotic postmenopausal women.

Última actualización 11/12/09Archer DF, Pinkerton JV, Utian WH, Menegoci JC, de Villiers TJ, Yuen CK, Levine AB, Chines AA, Constantine GD. Menopause. 2009 Nov-Dec;16(6):1079-82. OBJECTIVE: The aim of this study was to evaluate the endometrial, ovarian, and breast safety of bazedoxifene used as a treatment for postmenopausal osteoporosis. METHODS: Healthy …

Leer más »

Recognition and management of vitamin D deficiency.

Última actualización 2/12/09Am Fam Physician. 2009 Oct 15;80(8):841-6. Bordelon P, Ghetu MV, Langan RC. Vitamin D deficiency affects persons of all ages. Common manifestations of vitamin D deficiency are symmetric low back pain, proximal muscle weakness, muscle aches, and throbbing bone pain elicited with pressure over the sternum or tibia. …

Leer más »

Diagnosis and treatment of osteoporosis

Última actualización 27/02/09American Family Physician 79 (3), 193-200 (Feb 2009) Sweet MG, Sweet JM, Jeremiah MP, Galazka SS; Osteoporosis affects approximately 8 million women and 2 million men in the United States. The associated fractures are a common and preventable cause of morbidity and mortality in up to 50 percent …

Leer más »

Osteoporosis and osteoporotic fracture occurrence and prevention in the elderly: a geriatric perspective

Última actualización 17/12/08Best Pract Res Clin Endocrinol Metab. 2008 Oct;22(5):765-85. Boonen S, Dejaeger E, Vanderschueren D, Venken K, Bogaerts A, Verschueren S, Milisen K. Age is a major determinant of osteoporosis, but the elderly are rarely assessed and often remain untreated for this condition. Falls, co-morbidities and co-medications compound the …

Leer más »

Lithium’s effect on bone mineral density

Última actualización 9/12/08Bone. 2008 Oct 18. [Epub ahead of print] Zamani A, Omrani GR, Nasab MM. Lithium salts are widely used in treating psychiatric patients. Lithium may be associated with hyperparathyroidism, a risk factor for osteoporosis. However, the data on the effect of lithium on bone mass are conflicting. We …

Leer más »

Cancellous and cortical bone architecture and turnover at the iliac crest of postmenopausal osteoporotic women treated with parathyroid hormone 1-84

Última actualización 19/11/08Bone. 2008 Oct 17. [Epub ahead of print] Recker RR, Bare SP, Smith SY, Varela A, Miller MA, Morris SA, Fox J. Treatment with parathyroid hormone [PTH(1-84)] increases lumbar spine bone mineral density and decreases vertebral fractures, but its effects on bone microarchitecture are unknown. We obtained iliac …

Leer más »